CAS No.: 1701408-75-4
Molecular Formula: C30H29N5O6 | Molecular Weight: 555.59
Dosage Form: Capsule (12.5mg, 25mg, 37.5mg, 50mg) | Manufacturer: Pfizer
Product Overview
Sutetinib Maleate is an orally active tyrosine kinase inhibitor, which is the maleate form of Sutetinib, mainly used for the treatment of various solid tumors with independent IP and broad clinical application prospects.
Mechanism of Action
• Potently inhibits VEGFR1-3, PDGFRα/β and cKIT, blocking tumor growth and angiogenesis.
• Inhibits endothelial and fibroblast proliferation, migration, and exerts anti-tumor effects in multiple tumor cell lines.
China [CN] 
Click enlarge Image